Bioethics, Ltd.
BOTH
$1.25
$0.70127.27%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -15.27% | 70.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -15.27% | 70.87% | |||
| Operating Income | 15.27% | -70.87% | |||
| Income Before Tax | 9.04% | -47.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 9.04% | -47.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 9.04% | -47.91% | |||
| EBIT | 15.27% | -70.87% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 59.83% | -47.63% | |||
| Normalized Basic EPS | 59.59% | -47.47% | |||
| EPS Diluted | 59.83% | -47.63% | |||
| Normalized Diluted EPS | 59.59% | -47.47% | |||
| Average Basic Shares Outstanding | 126.12% | 0.00% | |||
| Average Diluted Shares Outstanding | 126.12% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||